About us
About us
Team
Investors
Technology
Pipeline
Pipeline
About AMD
PST-611
PST-809
News & Events
Press Releases
Events
In the News
Contact
Press release
January 16, 2025
PulseSight Therapeutics submits Clinical Trial Authorisation for phase I trial of PST-611
BACK
